Tag: Merck

Merck to acquire Caraway Therapeutics in $610m deal for neurodegenerative disease treatments

businessnewstoday- November 22, 2023

Merck and Caraway Therapeutics, Inc. have announced a definitive agreement in which Merck, through a subsidiary, will acquire Caraway Therapeutics. The total potential consideration for ... Read More

Merck strikes €1.4bn deal with Hengrui Pharmaceuticals for next-gen oncology treatments

businessnewstoday- October 31, 2023

In a major advancement in cancer treatment, Merck, a frontrunner in science and technology, has declared a strategic collaboration with Jiangsu Hengrui Pharmaceuticals Co. Ltd. ... Read More

Merck launches Phase 3 CORALreef program for PCSK9 inhibitor MK-0616

businessnewstoday- August 25, 2023

Pharmaceutical giant Merck has announced the initiation of its groundbreaking Phase 3 clinical program, CORALreef, focusing on MK-0616—a novel, oral proprotein convertase subtilisin/kexin type 9 ... Read More

Merck’s WELIREG meets primary endpoint of PFS in Phase 3 RCC trial

businessnewstoday- August 20, 2023

Global pharmaceutical leader Merck has announced that WELIREG (belzutifan), its pioneering oral HIF-2α inhibitor, has achieved a critical milestone in its Phase 3 trial LITESPARK-005. ... Read More

CHMP endorses Merck’s gefapixant for EU approval for chronic cough treatment

businessnewstoday- July 22, 2023

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval for gefapixant, an investigational, non-narcotic, oral selective P2X3 receptor ... Read More

ENB Therapeutics completes Phase 1 trial enrollment for ENB-003

businessnewstoday- July 19, 2023

ENB Therapeutics, a biotechnology firm working on therapeutics targeting the endothelin B receptor (ETBR), announced the completion of its international Phase 1 ENBOLDEN-101 trial enrollment. ... Read More

Endo International introduces Noxafil generic version in US

businessnewstoday- July 2, 2023

Endo International has revealed that its Par Sterile Products division is now shipping posaconazole injection (18 mg/mL) in the United States. This marks the first ... Read More

Merck to acquire biotech company Prometheus Biosciences for $10.8bn

businessnewstoday- April 16, 2023

Merck has agreed to acquire Prometheus Biosciences, a Nasdaq-listed clinical-stage biotechnology company, in an all-cash deal worth around $10.8 billion, in a move to bolster ... Read More

Bristol Myers Squibb gets Reblozyl EC approval for anemia associated with NTD beta thalassemia

businessnewstoday- March 4, 2023

Bristol Myers Squibb (BMY) has secured full marketing authorization for Reblozyl (luspatercept) from the European Commission (EC) for treating anemia associated with non-transfusion-dependent (NTD) beta ... Read More

Moderna, Merck get FDA breakthrough status for mRNA-4157/V940, KEYTRUDA combo in melanoma

businessnewstoday- February 23, 2023

Moderna and Merck announced that the investigational personalized mRNA cancer vaccine mRNA-4157/V940 in combination with the latter’s lung cancer drug KEYTRUDA (pembrolizumab) has been given ... Read More